AU7715300A - Method of preventing osteoporosis - Google Patents
Method of preventing osteoporosisInfo
- Publication number
- AU7715300A AU7715300A AU77153/00A AU7715300A AU7715300A AU 7715300 A AU7715300 A AU 7715300A AU 77153/00 A AU77153/00 A AU 77153/00A AU 7715300 A AU7715300 A AU 7715300A AU 7715300 A AU7715300 A AU 7715300A
- Authority
- AU
- Australia
- Prior art keywords
- preventing osteoporosis
- osteoporosis
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15623499P | 1999-09-27 | 1999-09-27 | |
US60156234 | 1999-09-27 | ||
PCT/US2000/026357 WO2001022963A1 (en) | 1999-09-27 | 2000-09-25 | Method of preventing osteoporosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7715300A true AU7715300A (en) | 2001-04-30 |
Family
ID=22558694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU77153/00A Abandoned AU7715300A (en) | 1999-09-27 | 2000-09-25 | Method of preventing osteoporosis |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7715300A (en) |
WO (1) | WO2001022963A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2195293T3 (en) | 2007-08-22 | 2014-03-31 | Astrazeneca Ab | Cycloptopyl amide derivatives |
EP2095819A1 (en) * | 2008-02-28 | 2009-09-02 | Maastricht University | N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors |
TW201039825A (en) | 2009-02-20 | 2010-11-16 | Astrazeneca Ab | Cyclopropyl amide derivatives 983 |
RU2012136148A (en) | 2010-02-18 | 2014-03-27 | Астразенека Аб | NEW CRYSTAL FORM OF THE CYCLOPROPYLBENZAMIDE DERIVATIVE |
US9045445B2 (en) | 2010-06-04 | 2015-06-02 | Albany Molecular Research, Inc. | Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
SG11201407616TA (en) | 2012-05-17 | 2015-03-30 | Array Biopharma Inc | Process for making hydroxylated cyclopentylpyrimidine compounds |
SG11201407591PA (en) | 2012-05-17 | 2015-01-29 | Genentech Inc | Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof |
JP6196294B2 (en) | 2012-05-17 | 2017-09-13 | ジェネンテック, インコーポレイテッド | Process for producing amino acid compounds |
WO2013173736A1 (en) | 2012-05-17 | 2013-11-21 | Array Biopharma Inc. | Process for making hydroxylated cyclopentylpyrimidine compounds |
KR102125588B1 (en) | 2012-05-17 | 2020-06-22 | 제넨테크, 인크. | Amorphous form of an akt inhibiting pyrimidinyl - cyclopentane compound, compositions and methods thereof |
WO2015070367A1 (en) * | 2013-11-12 | 2015-05-21 | Merck Sharp & Dohme Corp. | Piperidine or piperazine linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11130670A (en) * | 1997-10-27 | 1999-05-18 | Oyo Seikagaku Kenkyusho | Osteoporosis therapeutic agent |
EP1088333A4 (en) * | 1998-06-24 | 2005-08-10 | Merck & Co Inc | Compositions and methods for inhibiting bone resorption |
-
2000
- 2000-09-25 AU AU77153/00A patent/AU7715300A/en not_active Abandoned
- 2000-09-25 WO PCT/US2000/026357 patent/WO2001022963A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001022963A1 (en) | 2001-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3867400A (en) | Methods of using bioelastomers | |
EP1143953A3 (en) | Method of inhibiting angiogenesis | |
AU3803600A (en) | Method of securing communication | |
AU2864499A (en) | Method of etching | |
AU2557500A (en) | Methods of making compounds | |
AU1882901A (en) | Pointing method | |
AU1854901A (en) | Novel method | |
AU3091599A (en) | Method of making dimethylnaphtalenes | |
AU7902400A (en) | Method for the preparation of 5-carboxyphthalide | |
AU7715300A (en) | Method of preventing osteoporosis | |
AU4156200A (en) | Method of receiving information | |
AU2728901A (en) | Method of making hydrofluorocarbons | |
AUPQ388399A0 (en) | A method of transformation | |
AU1130901A (en) | Method for the preparation of 5-carboxyphthalide | |
AU9119998A (en) | Method of time-to-talk calculation | |
AU5861700A (en) | Method of threading | |
EP1225621A4 (en) | Method of etching | |
AU4598400A (en) | Method of treatment | |
GB9924752D0 (en) | Method of construction | |
AU5552200A (en) | Method | |
AU1478201A (en) | Improved method of immunization | |
AU4585100A (en) | Method | |
AU2355501A (en) | Bone cement | |
AUPP939599A0 (en) | Method of rendering | |
AU1164401A (en) | Method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |